SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008952
Filing Date
2022-05-16
Accepted
2022-05-16 16:14:02
Documents
130
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aytu-20220331x10q.htm   iXBRL 10-Q 2458525
2 EX-10.1 aytu-20220331xex10d1.htm EX-10.1 293856
3 EX-31.1 aytu-20220331xex31d1.htm EX-31.1 15230
4 EX-31.2 aytu-20220331xex31d2.htm EX-31.2 14030
5 EX-32.1 aytu-20220331xex32d1.htm EX-32.1 14754
6 GRAPHIC aytu-20220331x10q001.jpg GRAPHIC 3651
7 GRAPHIC aytu-20220331xex10d1001.jpg GRAPHIC 1243
  Complete submission text file 0001558370-22-008952.txt   13472507

Data Files

Seq Description Document Type Size
8 EX-101.SCH aytu-20220331.xsd EX-101.SCH 101324
9 EX-101.CAL aytu-20220331_cal.xml EX-101.CAL 108386
10 EX-101.DEF aytu-20220331_def.xml EX-101.DEF 459325
11 EX-101.LAB aytu-20220331_lab.xml EX-101.LAB 820100
12 EX-101.PRE aytu-20220331_pre.xml EX-101.PRE 765717
124 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20220331x10q_htm.xml XML 2582860
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 22929164
SIC: 2834 Pharmaceutical Preparations